From our conversations with device companies, investors and surgeons, it's become clear that companies that are able to capitalize on these three aspects of care will be best positioned to maintain or grow their share of the joint reconstruction market.
What portion of new products introduced in joint reconstruction and spine are additively manufactured? To investigate, we tracked product launches and regulatory announcements from January 2015 to 2017.
Dr. Muratoglu is Director of the Harris Orthopaedic Laboratory and Director of the Technology Implementation Research Center at Massachusetts General Hospital, and Professor of Orthopaedic Surgery at Harvard Medical School. He's also an ORTHOWORLD Member.